drugset / Trial / NCT00830492

Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

NCT00830492

Phase 4 Completed 200 enrolled Yazd Research & Clinical Center for Infertility
RandomizedParallel-groupSingle-blindTreatment

Summary

Objective: To compare the efficacy of using mild ovarian stimulation protocol and conventional stimulation protocol in IVF outcome. Design: Prospective randomized trial Setting: University IVF setting. Patient(s): The study compromised a total 200 subinfertile couple that women had regulary menstruation. Intervention(s): Patients were randomized to treatment clomiphene citrate, gonadotropin and GnRH antagonist (100 patients) or GnRH agonist and gonadotropin ( 100 patients). Main outcome measure: Clinical pregnancy rate. Key Words: clomiphene citrate, GnRH agonist, GnRH antagonist, in vitro fertilization, pregnancy rate.

Timeline

Start
2008-01
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 100 mg
Subject Ganirelix Protein / enzyme biologic
Comparator Gonal-f Protein / enzyme biologic 150 iu Subcutaneous
Comparator Gonal-f Protein / enzyme biologic 225 iu Subcutaneous
Comparator buserelin Unknown 250 ug Subcutaneous
Subject human chorionic gonadotropin Protein / enzyme biologic 75 iu